Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CPU0213

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Objectives  Abnormal vascular activity in diabetes is related not only to impaired nitric oxide bioavailability but also to… Expand
2009
2009
AbstractAim:Spatial dispersion of bioactive substances in the myocardium could serve as pathological basis for arrhythmogenesis… Expand
  • figure 1
  • figure 2
  • figure 3
2008
2008
Background/Aims: NADPH oxidase(NOX) is the main source of reactive oxygen species (ROS) in diabetic nephropathy (DN). Activation… Expand
  • table 1
2008
2008
Downregulation of FKBP12.6 and sarcoplasmic reticulum Ca(2+) ATPase (SERCA2a) contributes to sudden cardiac death and heart… Expand
2008
2008
It has been verified that endothelin-1 (ET-1) activates matrix metalloproteinase (MMP) in the process of myocardial remodeling… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2007
2007
1 The aims of the present study were to examine whether: (i) upregulation of the endothelin (ET) pathway is involved in… Expand
2007
2007
Arrhythmias correlate with disorders of either K(2+) channels in sarcolemma or calcium modulating system in sarcoplasmic… Expand
  • figure 2
  • figure 1
  • figure 4
  • figure 3
  • figure 5
2007
2007
AbstractAim:The downregulation of phospholamban (PLB) and FKBP12.6 as a result of β-receptor activation is involved in the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
2006
2006
The depressed sarcoplasmic reticulum (SR) Ca2+-ATPase (SERCA2a) and Ca2+-release channels (ryanodine receptor RyR2) are involved… Expand
2006
2006
AbstractAim:To examine whether a novel endothelin receptor antagonist, CPU0213, is effective in relieving the acute renal failure… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3